The VEGF receptor, neuropilin-1, represents a promising novel target for chronic lymphocytic leukemia patients

Lenalidomide treatment of chronic lymphocytic leukaemia patients reduces regulatory T cells and induces Th17 T helper cells

(2009) Irina Idler et al.   BRITISH JOURNAL OF HAEMATOLOGY

Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value

(2009) Jian-guo Sun et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia

(2009) K Giannopoulos et al.   LEUKEMIA

Neuropilin-1 Expression on Regulatory T Cells Enhances Their Interactions with Dendritic Cells during Antigen Recognition

(2008) Milka Sarris et al.   IMMUNITY

Neuropilin-1 in acute myeloid leukemia: Expression and role in proliferation and migration of leukemia cells

(2008) Lin Lu et al.   LEUKEMIA & LYMPHOMA

Neuropilin-1 is expressed by chronic lymphocytic leukemia B cells

(2008) Grzegorz S. Nowakowski et al.   LEUKEMIA RESEARCH